Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Smith & Nephew Snats ADR (SNN)

Smith & Nephew Snats ADR (SNN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,127,166
  • Shares Outstanding, K 436,229
  • Annual Sales, $ 5,212 M
  • Annual Income, $ 524,000 K
  • 60-Month Beta 0.68
  • Price/Sales 2.30
  • Price/Cash Flow 9.63
  • Price/Book 2.21
Trade SNN with:

Options Overview Details

View History
  • Implied Volatility 64.40% ( +19.17%)
  • Historical Volatility 24.77%
  • IV Percentile 95%
  • IV Rank 75.66%
  • IV High 78.04% on 03/10/22
  • IV Low 22.00% on 08/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 221
  • Open Int (30-Day) 1,250

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.91 +3.31%
on 07/05/22
31.75 -12.45%
on 06/07/22
-3.81 (-12.05%)
since 06/06/22
3-Month
26.91 +3.31%
on 07/05/22
34.12 -18.52%
on 04/21/22
-4.26 (-13.29%)
since 04/06/22
52-Week
26.91 +3.31%
on 07/05/22
44.22 -37.13%
on 07/07/21
-16.14 (-36.73%)
since 07/06/21

Most Recent Stories

More News
Now is a Great Time to Pick Up This Passive Income Stock

The surging inflation and the Fed’s efforts to tame it by aggressively hiking interest rates have led to many analysts forecasting a recession later this year. Investors must consider picking up stocks...

FONR : 14.85 (+0.68%)
MDT : 89.62 (-0.96%)
OCPNY : 20.0500 (unch)
SNN : 27.80 (+1.28%)
SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds...

SNN : 27.80 (+1.28%)
5 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows to Scoop Up Right Now

The healthcare industry is expected to grow significantly in 2022, thanks to strong demand amid rising chronic diseases, an aging population, and digital integration in healthcare systems. Furthermore,...

ABT : 108.69 (-0.56%)
FMS : 24.21 (-1.55%)
MDT : 89.62 (-0.96%)
QDEL : 105.06 (+4.63%)
SNN : 27.80 (+1.28%)
5 Resilient Stocks to Buy for a Market Downturn

Yesterday, the broad market indices closed in negative territory on interest-rate-increase concerns. Goldman Sachs has predicted that the S&P might tumble to 3,600 this year if recessionary pressure persists....

BG : 85.85 (-0.89%)
BIPC : 42.10 (+1.20%)
CAH : 52.64 (+0.75%)
SNN : 27.80 (+1.28%)
VRTX : 291.16 (+0.75%)
Buy These 5 Defensive Stocks to Protect Your Portfolio from Market Volatility

Defensive stocks are known for exhibiting stability during wild price swings in the market. And growing sanctions on Russia and the unstable nature of crude oil prices may drive further volatility in the...

CVS : 93.19 (+0.71%)
BDX : 246.28 (-0.67%)
CL : 81.02 (+0.02%)
SNN : 27.80 (+1.28%)
INGR : 87.61 (-1.23%)
Trading Near 52-Week Lows: Grab These 5 Undervalued Healthcare Stocks Now

Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple...

GILD : 62.73 (+0.63%)
SNN : 27.80 (+1.28%)
QGEN : 48.40 (+0.17%)
RDY : 55.98 (+0.20%)
MD : 22.32 (-0.89%)
Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical

Smith+Nephew's (SNN) acquisition of Engage Surgical reinforces its growth strategy while expanding its Orthopaedic Reconstruction product line.

JNJ : 178.30 (+0.09%)
SNN : 27.80 (+1.28%)
ZBH : 105.73 (-1.09%)
CFMS : 0.3500 (-1.85%)
Smith+Nephew (SNN) Introduces Real Intelligence & CORI System

Smith+Nephew (SNN) debuts new brand of enabling technology solutions as well as its next-generation handheld robotics platform in Canada.

SNN : 27.80 (+1.28%)
OMCL : 115.76 (-0.74%)
AMN : 110.47 (-0.11%)
VREX : 20.85 (-2.20%)
Smith+Nephew (SNN) Rolls Out Robotic Assisted Surgical System

Smith+Nephew's (SNN) CORI system enables each patient to have a knee replacement that is shape-matched and aligned to their specific anatomy.

LH : 243.88 (+1.62%)
SNN : 27.80 (+1.28%)
TMO : 556.04 (+2.01%)
MEDP : 152.47 (-2.70%)
3 Stocks That Could Bounce Back in the Fourth Quarter

Despite concerns surrounding the Fed tapering asset purchases, many analysts expect stocks to continue making new highs after a turbulent period in September. Thus, fundamentally sound stocks Smith & Nephew...

SNN : 27.80 (+1.28%)
DVA : 80.24 (-2.23%)
OFIX : 24.14 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Key Turning Points

3rd Resistance Point 28.43
2nd Resistance Point 28.24
1st Resistance Point 28.02
Last Price 27.80
1st Support Level 27.60
2nd Support Level 27.41
3rd Support Level 27.19

See More

52-Week High 44.22
Fibonacci 61.8% 37.61
Fibonacci 50% 35.57
Fibonacci 38.2% 33.52
Last Price 27.80
52-Week Low 26.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar